NCT00771212

Brief Summary

The purpose of this study is to describe the use of pain treatments in Taiwan, the demographics, clinical characteristics of patients requiring pain treatments, current treatments, outcomes of treatments and the reasons for changing pain medication during treatment.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,636

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2007

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2007

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2008

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 10, 2008

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 13, 2008

Completed
Last Updated

May 23, 2014

Status Verified

May 1, 2014

Enrollment Period

7 months

First QC Date

October 10, 2008

Last Update Submit

May 22, 2014

Conditions

Keywords

PainObservationalTaiwan

Outcome Measures

Primary Outcomes (1)

  • To describe effective use of pain medications, describe demographics, clinical characteristics of patients requiring pain treatments, current treatments, outcomes of treatments and the reasons for changing pain medication during treatment in Taiwan

    60 days

Secondary Outcomes (3)

  • Pain Relief Rating Scale

    60 days

  • Sleeping quality Assessment

    60 days

  • Global Assessments (Patient/Investigator)

    60 days

Study Arms (1)

001

Other: Observational pain control study

Interventions

Observational pain control study

001

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Outpatients; Patients must have pain, previously treated with and without medication and have a VAS (Visual analogue scale) score recorded at the enrolment time; Patient must have a VAS score \>4

You may qualify if:

  • Outpatients only
  • Patients must have pain, previously treated with and without medication and have a VAS (Visual analogue scale) score recorded at the enrolment time
  • Patient must have a VAS score \>4

You may not qualify if:

  • Patients who are receiving any investigational drug during the study
  • Patients with known or suspected psychotic disease or mental retardation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Johnson & Johnson Taiwan, Ltd. Clinical Trial

    Johnson & Johnson Taiwan Ltd

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 10, 2008

First Posted

October 13, 2008

Study Start

October 1, 2007

Primary Completion

May 1, 2008

Study Completion

May 1, 2008

Last Updated

May 23, 2014

Record last verified: 2014-05